Literature DB >> 5010725

Successful medical management of osteitis fibrosa due to "tertiary" hyperparathyroidism.

W M Vosik, C F Anderson, W P Steffee, W J Johnson, C D Arnaud, R S Goldsmith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5010725

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  3 in total

1.  Metabolic bone disease in chronic renal failure. I. Dialyzed uremics.

Authors:  W E Huffer; D Kuzela; M M Popovtzer
Journal:  Am J Pathol       Date:  1975-03       Impact factor: 4.307

2.  Suppression of secondary hyperparathyroidism in uraemia: acute and chronic studies.

Authors:  N Muirhead; G R Catto; N Edward; S Adami; R M Manning; J L O'Riordan
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-21

3.  Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibility.

Authors:  R S Goldsmith; J Furszyfer; W J Johnson; A E Fournier; G W Sizemore; C D Arnaud
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.